Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMITRIPTYLINE Cause Respiratory failure? 159 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Respiratory failure have been filed in association with AMITRIPTYLINE (AMITRIPTYLINE HYDROCHLORIDE). This represents 0.8% of all adverse event reports for AMITRIPTYLINE.

159
Reports of Respiratory failure with AMITRIPTYLINE
0.8%
of all AMITRIPTYLINE reports
29
Deaths
135
Hospitalizations

How Dangerous Is Respiratory failure From AMITRIPTYLINE?

Of the 159 reports, 29 (18.2%) resulted in death, 135 (84.9%) required hospitalization, and 75 (47.2%) were considered life-threatening.

Is Respiratory failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMITRIPTYLINE. However, 159 reports have been filed with the FAERS database.

What Other Side Effects Does AMITRIPTYLINE Cause?

Toxicity to various agents (3,001) Drug ineffective (2,344) Completed suicide (1,678) Off label use (1,588) Pain (1,300) Fall (1,216) Hypotension (1,205) Drug abuse (1,116) Dizziness (1,041) Constipation (1,035)

What Other Drugs Cause Respiratory failure?

PREDNISONE (2,299) CYCLOPHOSPHAMIDE (2,096) RITUXIMAB (1,838) TACROLIMUS (1,758) METHOTREXATE (1,685) DEXAMETHASONE (1,603) MYCOPHENOLATE MOFETIL (1,469) METHYLPREDNISOLONE (1,442) PREDNISOLONE (1,346) VINCRISTINE (1,120)

Which AMITRIPTYLINE Alternatives Have Lower Respiratory failure Risk?

AMITRIPTYLINE vs AMITRIPTYLINE\PERPHENAZINE AMITRIPTYLINE vs AMIVANTAMAB AMITRIPTYLINE vs AMIVANTAMAB-VMJW AMITRIPTYLINE vs AMLODIPINE AMITRIPTYLINE vs AMLODIPINE BESILATE

Related Pages

AMITRIPTYLINE Full Profile All Respiratory failure Reports All Drugs Causing Respiratory failure AMITRIPTYLINE Demographics